q3 adjusted operating earnings per share $2.98.
qtrly adjusted operating loss per share $0.12.
qtrly net sales of $2.8 billion, up 52% year-over-year.
sees q4 term life margin in range of 19% to 20%.
sees fy sales to be about 10% above pre-pandemic levels.
sees q4 investment sales to grow between 20% and 25% year over year.
sees q4 sales down 13% to 15%.
compname reports q3 earnings per share of $0.19.